Author: Dr. David Lowemann

Next-Gen Novo Drug Shows 15.7 Percent Weight Loss

Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with Type 2 diabetes cut their weight by 15.7% after 68 weeks. The data is seen as crucial for the future potential for its experimental next-generation obesity… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on March 10, 2025

Levels of select vitamins and minerals in pregnancy may be linked to lower midlife BP risk

Higher levels of the minerals copper and manganese in pregnant women were associated with lower blood pressure and a reduced risk of developing high blood pressure decades later, according to a long-term study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of […]

Published on March 9, 2025

Top US Health Agency Makes $25,000 Buyout Offer to Most of Its Employees

Most of the 80,000 federal workers responsible for researching diseases, inspecting food and administering Medicare and Medicaid under the auspices of the Health and Human Services Department were emailed an offer to leave their job for as much as a $25,000 payment as part… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on March 9, 2025